Filing summary
Haleon plc filed a Form 6-K for October 2026, attaching its 1 October 2026 notice of total voting rights and share capital. The notice reports share counts as at 30 September 2026.
Share capital and voting rights
- Issued ordinary shares of £0.01 each: 8,808,341,409.
- Shares held in treasury: 11,763,163.
- Ordinary shares with voting rights: 8,796,578,246. Haleon says shareholders should use this figure as the denominator when assessing notification obligations under the FCA’s Disclosure Guidance and Transparency Rules.
Financial performance, outlook and risks
This filing contains no revenue, profit, cash flow, margin, debt, liquidity, guidance, or outlook information. It does not report material operating changes, contingencies, or unusual items.
Business context
Haleon describes itself as a consumer health company focused on everyday health, with products across six categories: Oral Health; Vitamins, Minerals and Supplements; Pain Relief; Respiratory Health; Digestive Health; and Therapeutic Skin Health and Other.
Key facts to verify
- Confirm the reported share and treasury-share counts against the company’s share register or subsequent notices.
- Use 8,796,578,246 voting shares as the denominator for relevant FCA disclosure calculations as directed in the notice.